SCHEMBL12819956

SCHEMBL12819956

BCC(=O)c1ccc(-c2ccc(C(=O)CB)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ MAPT P10636 4/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ PTPN1 P18031 1/20 0.50
▸ GSK3B P49841 1/20 0.50
▸ LMNA P02545 2/20 0.48
▸ FFAR1 O14842 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ HAO1 Q9UJM8 4/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ERCC5 P28715 1/20 0.47
▸ FEN1 P39748 1/20 0.47
▸ MMP2 P08253 4/20 0.46
▸ MMP9 P14780 4/20 0.46
▸ MMP8 P22894 4/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ SRD5A2 P31213 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12333038 0.91 SMN1; SMN2 (0.44) SMN1; SMN2MAPTL3MBTL1PTPN1GSK3B
SCHEMBL13557299 0.89 GSK3B (0.68) SMN1; SMN2MAPTL3MBTL1PTPN1GSK3B
SCHEMBL12647724 0.84 PTPN1 (0.44) SMN1; SMN2MAPTL3MBTL1PTPN1GSK3B
SCHEMBL12300577 0.82 GSK3B (0.38) SMN1; SMN2MAPTL3MBTL1PTPN1GSK3B
SCHEMBL12153522 0.82 NPC1 (0.60) MAPTL3MBTL1PTPN1LMNARAB9A
SCHEMBL13655368 0.80 TPMT (0.52) PTPN1GSK3BRAB9A
SCHEMBL7999198 0.80 GSK3B (0.61) SMN1; SMN2MAPTL3MBTL1GSK3BLMNA
SCHEMBL13191468 0.80 MAPT (0.45) MAPTLMNACYP1A2RAB9AHIF1A
SCHEMBL8751033 0.80 GSK3B (0.64) GSK3BLMNARAB9AHAO1HPGD
SCHEMBL12659978 0.80 GSK3B (0.64) MAPTL3MBTL1GSK3BLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183244-B1 CRYSTALLINE FORM OF METHYL ((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYLBUTANOYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)-4-BIPHENYLYL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)CARBAMATE DIHYDROCHLORIDE SALT BRISTOL MYERS SQUIBB CO (US) 2013-01-23 — — EP disclosed
WO-2011028596-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-03-10 — — WO disclosed
Send feedback